Form 4: Aimee S. Weisner Reports Changes in Beneficial Ownership of STAAR Surgical Co.

Director Aimee S. Weisner reports acquisition of 4,488 shares of STAAR Surgical Co. common stock through a restricted stock grant.

Summary

• Aimee S. Weisner, a director of STAAR Surgical Co., filed a Form 4 to report changes in beneficial ownership.
• On June 20, 2024, Ms. Weisner acquired 4,488 shares of common stock through a restricted stock grant.
• These shares were granted as part of the Corporation's annual non-employee director equity compensation program for the 2024-2025 term.
• The restricted stock vests in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders.
• Following the transaction, Ms. Weisner beneficially owns 15,352 shares of STAAR Surgical Co. common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The grant of restricted stock can be seen as a positive sign of aligning director interests with shareholder value.

Positives

• The grant of restricted stock aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure related to director compensation and is typical for publicly traded companies. It reflects standard practices for aligning director interests with shareholder value through equity-based compensation.

Comparison to Industry Standards

• Equity compensation for non-employee directors is a common practice among publicly traded companies, including those in the medical device industry.
• Companies like Alcon, Johnson & Johnson, and Bausch + Lomb also utilize stock grants and options as part of their director compensation packages.
• The vesting schedules and grant sizes are generally aligned with industry norms to incentivize long-term commitment and performance.

Stakeholder Impact

• The stock grant aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• The equity compensation program can help attract and retain qualified directors.

Key Dates